Search alternatives:
nm decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
mm decrease » nn decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
50 mm » 10 mm (Expand Search), 50 mg (Expand Search), 20 mm (Expand Search)
5 nm » 5 mm (Expand Search), 5 cm (Expand Search)
nm decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
mm decrease » nn decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
50 mm » 10 mm (Expand Search), 50 mg (Expand Search), 20 mm (Expand Search)
5 nm » 5 mm (Expand Search), 5 cm (Expand Search)
-
1
-
2
-
3
Predictive values of IC<sub>50</sub> in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC<sub>50</sub> in mM (FFAs) and decreasing blood glucose level.
Published 2014“…<p>Predictive values of IC<sub>50</sub> in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC<sub>50</sub> in mM (FFAs) and decreasing blood glucose level.…”
-
4
Corticosterone treatment decreases MMP-2 promoter activity.
Published 2012“…MMP-2 mRNA levels were decreased with corticosterone treatment (A) (p = 0.006, n = 5). …”
-
5
-
6
-
7
-
8
-
9
Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50.
Published 2024“…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
-
10
Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.
Published 2023“…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM.
Published 2013“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
-
19
-
20